HedgeChatter

  • Home /
  • Tag Archives

BIOD

Biodel Completes Enrollment in Phase 2 Clinical Trial of Ultra-Rapid-Acting Insulin Candidate BIOD-123 for the Treatment of Diabetes

[at noodls] – Top-Line Data Expected in Third Quarter 2013 DANBURY, Conn., March 28, 2013 (GLOBE NEWSWIRE) — Biodel Inc. (Nasdaq:BIOD) today announced the completion of patient enrollment in a Phase 2 clinical study … moreView todays social media effects on BIODView the latest stocks trending across Twitter. Click to view dashboardSee who Biodel is hiring next, click here to […]

March 28, 2013 Bystocknews , Comments Off on Biodel Completes Enrollment in Phase 2 Clinical Trial of Ultra-Rapid-Acting Insulin Candidate BIOD-123 for the Treatment of Diabetes read more

Biodel Reports First Quarter Fiscal Year 2013 Financial Results

[at noodls] – Conference Call and Audio Webcast Will be Held Today, February 12th, at 5:00 p.m. ET DANBURY, Conn., Feb. 12, 2013 (GLOBE NEWSWIRE) — Biodel Inc. (Nasdaq:BIOD) today reported financial results for the … moreView todays social media effects on BIODView the latest stocks trending across Twitter. Click to view dashboardSee who Biodel is hiring next, click here […]

February 12, 2013 Bystocknews , Comments Off on Biodel Reports First Quarter Fiscal Year 2013 Financial Results read more

Biodel to Report First Quarter Fiscal Year 2013 Financial Results on February 12, 2013

[at noodls] – DANBURY, Conn., Feb. 6, 2013 (GLOBE NEWSWIRE) — Biodel Inc. (Nasdaq:BIOD) will issue its first quarter fiscal year 2013 financial results on February 12, 2013. Following the release of the company’s financial … moreView todays social media effects on BIODView the latest stocks trending across Twitter. Click to view dashboardSee who Biodel is hiring next, click here […]

February 6, 2013 Bystocknews , Comments Off on Biodel to Report First Quarter Fiscal Year 2013 Financial Results on February 12, 2013 read more

Biodel to Present at 2013 BIO CEO and Investor Conference

[at noodls] – DANBURY, Conn., Feb. 5, 2013 (GLOBE NEWSWIRE) — Biodel Inc. (Nasdaq:BIOD) announced today that management will be presenting an overview of the company’s technologies, development programs, and outlook … moreView todays social media effects on BIODView the latest stocks trending across Twitter. Click to view dashboardSee who Biodel is hiring next, click here to view […]

February 5, 2013 Bystocknews , Comments Off on Biodel to Present at 2013 BIO CEO and Investor Conference read more

CORRECTION — Biodel Reports Positive Top-Line Results From Clinical Study of Ultra-Rapid-Acting Insulin Analog Candidates

[at noodls] – DANBURY, Conn., Jan. 24, 2013 (GLOBE NEWSWIRE) — In a release issued earlier today by Biodel Inc. (Nasdaq:BIOD), one reference to BIOD-238 should have been BIOD-250 in the fourth paragraph. The corrected … moreView todays social media effects on BIODView the latest stocks trending across Twitter. Click to view dashboardSee who Biodel is hiring next, click here […]

January 24, 2013 Bystocknews , Comments Off on CORRECTION — Biodel Reports Positive Top-Line Results From Clinical Study of Ultra-Rapid-Acting Insulin Analog Candidates read more

Biodel Reports Positive Top-Line Results From Clinical Study of Ultra-Rapid-Acting Insulin Analog Candidates

[at noodls] – BIOD-238 and BIOD-250 demonstrate a pharmacokinetic profile superior to Humalog® with ultra-rapid absorption and rapid declines from peak concentration BIOD-250 demonstrates injection site toleration comparable … moreView todays social media effects on BIODView the latest stocks trending across Twitter. Click to view dashboardSee who Biodel is hiring next, click here to view […]

January 24, 2013 Bystocknews , Comments Off on Biodel Reports Positive Top-Line Results From Clinical Study of Ultra-Rapid-Acting Insulin Analog Candidates read more

Biodel Reports Fourth Quarter Fiscal Year 2012 Financial Results

[at noodls] – Conference Call and Audio Webcast Will be Held Today, December 18th, at 8:00 a.m. ET DANBURY, Conn., Dec. 18, 2012 (GLOBE NEWSWIRE) — Biodel Inc. (Nasdaq:BIOD) today reported financial results for the … moreView todays social media effects on BIODView the latest stocks trending across Twitter. Click to view dashboardSee who Biodel is hiring next, click here […]

December 18, 2012 Bystocknews , Comments Off on Biodel Reports Fourth Quarter Fiscal Year 2012 Financial Results read more

Biodel to Report Fourth Quarter Fiscal Year 2012 Financial Results on December 18, 2012

[at noodls] – DANBURY, Conn., Dec. 14, 2012 (GLOBE NEWSWIRE) — Biodel Inc. (Nasdaq:BIOD) will issue its fourth quarter fiscal year 2012 financial results on December 18, 2012. Following the release of the company’s … moreView todays social media effects on BIODView the latest stocks trending across Twitter. Click to view dashboardSee who Biodel is hiring next, click here to […]

December 14, 2012 Bystocknews , Comments Off on Biodel to Report Fourth Quarter Fiscal Year 2012 Financial Results on December 18, 2012 read more

FDA Grants Orphan Drug Designation to Biodel’s Glucagon for Prevention of Hypoglycemia in Congenital Hyperinsulinism Population

[at noodls] – FDA Grants Orphan Drug Designation to Biodel’s Glucagon for Prevention of Hypoglycemia in Congenital Hyperinsulinism Population DANBURY, Conn., Dec. 6, 2012 (GLOBE NEWSWIRE) — Biodel Inc. (Nasdaq:BIOD) … moreView todays social media effects on BIODView the latest stocks trending across Twitter. Click to view dashboardSee who Biodel is hiring next, click here to view […]

December 6, 2012 Bystocknews , Comments Off on FDA Grants Orphan Drug Designation to Biodel’s Glucagon for Prevention of Hypoglycemia in Congenital Hyperinsulinism Population read more